Trademark/Service Mark Application, Principal Register
PTO- 1478
Approved for use through 02/28/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Approved for use through 02/28/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Serial Number:90510793
Filing Date:02/04/2021
To the Commissioner for Trademarks:
MARK: REBOOT. RELIEVE. REFRESH. (Standard Characters, see mark)
The literal element of the mark consists of REBOOT. RELIEVE. REFRESH.. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Allergan, Inc., a corporation of Delaware, having an address of
2525 Dupont Drive
Irvine, California 92612
United States
847-938-2623(fax)
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: Ophthalmic preparations; Eye drops; Lubricating and rewetting solutions for eyes
In International Class 005, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 06/14/2019, and first used in
commerce at least as early as 07/31/2019, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any
item in the class of listed goods/services, consisting of a(n) Digital images of website pages..
Webpage URL: http://refresh.refreshmyeyes.com/96952.html?lang=en_US
Webpage Date of Access: 02/04/2021
The applicant's current Correspondence Information:
Allergan, Inc.
PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@abbvie.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): trademarks@abbvie.com; kimberly.gleason@abbvie.com; matthew.brady@allergan.com
The docket/reference number is REBOOT.RELIE.
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $350 has been submitted with the application, representing payment for 1 class(es).
Declaration
Declaration Signature
Signature: /mob/ Date: 02/04/2021
Signatory's Name: Matthew O. Brady
Signatory's Position: Vice President
Signatory's Phone Number: 714-246-4788
Signature method: Signed directly within the form
Payment Sale Number: 90510793
Payment Accounting Date: 02/04/2021
Serial Number: 90510793
Internet Transmission Date: Thu Feb 04 16:09:55 ET 2021
TEAS Stamp: USPTO/BAS-XXX.XXX.XXX.XX-202102041609551
75913-90510793-7602d3133d095eba03f1c3422
c887a4e26cfb4a12ee2425ca8c9fc9415ec51107
4-DA-09541593-20210204155059627078